Metabonomics study of brain-specific human S100B transgenic mice by using high-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 6, 2011, Pages 871-876

  Liu, Jia Lin ^a   Wang, Hai Lin ^a   Zhang, Lian Feng ^a   Xu, Yan Feng ^a   Deng, Wei ^a   Zhu, Hua ^a   Qin, Chuan ^a  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Mesencephalon profiling; Metabonomic; Parkinson's disease; S100B; Transgenic mouse

Indexed keywords

4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER; GLUTAMIC ACID; HISTIDINE; PHENYLALANINE; PROTEIN S100B; TRYPTOPHAN;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; INSTRUMENT VALIDATION; MALE; MESENCEPHALON; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; ROTAROD TEST; SENSITIVITY ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; MESENCEPHALON; METABOLOMICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE GROWTH FACTORS; NEURONS; PARKINSON DISEASE; PLATELET-DERIVED GROWTH FACTOR; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 79958019946     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.871     Document Type: Article

References (18)

1. Wilhelm K. R., Yanamandra K., Gruden M. A., Zamotin V., Malisauskas M., Casaite V., Darinskas A., Forsgren L., Morozova-Roche L. A., Eur. J. Neurol., 14, 327-334 (2007).
2. Schaf D. V., Tort A. B., Fricke D., Schestatsky P., Portela L. V., Souza D. O., Rieder C. R., Parkinsonism Relat. Disord., 11, 39-43 (2005).
3. Himeda T., Watanabe Y., Tounai H., Hayakawa N., Kato H., Araki T., J. Neural Transm., 113, 1887-1894 (2006).
4. Nicholson J. K., Connelly J., Lindon J. C., Holmes E., Nat. Rev. Drug Discov., 1, 153-161 (2002).
5. Yin P., Mohemaiti P., Chen J., Zhao X., Lu X., Yimiti A., Upur H., Xu G., J. Chromatogr. B, 871, 322-327 (2008).
6. Kellert M., Wagner S., Lutz U., Lutz W. K., Chem. Res. Toxicol., 21, 761-768 (2008).
7. Jia L., Wang C., Kong H., Yang J., Li F., Lv S., Xu G., J. Pharm. Biomed. Anal., 43, 646-654 (2007).
8. Wang Y., Wang J., Yao M., Zhao X., Fritsche J., Schmitt-Kopplin P., Cai Z., Wan D., Lu X., Yang S., Gu J., Haring H. U., Schleicher E. D., Lehmann R., Xu G., Anal. Chem., 80, 4680-4688 (2008).
9. Idborg H., Zamani L., Edlund P. O., Schuppe-Koistinen I., Jacobsson S. P., J. Chromatogr. B, 828, 9-13 (2005).
10. Hodson M. P., Dear G. J., Roberts A. D., Haylock C. L., Ball R. J., Plumb R. S., Stumpf C. L., Griffin J. L., Haselden J. N., Anal. Biochem., 362, 182-192 (2007).
11. Bijlsma S., Bobeldijk I., Verheij E. R., Ramaker R., Kochhar S., Macdonald I. A., van Ommen B., Smilde A. K., Anal. Chem., 78, 567-574 (2006).
12. Hu L. F., Wang S., Shi X. R., Yao H. H., Sun Y. H., Ding J. H., Liu S. Y., Hu G., J. Neurochem., 94, 1570-1579 (2005).
13. Bonnet A. M., Tell G., Schechter P. J., Grove J., Saint-Hilaire M. H., De Smet Y., Agid Y., Mov. Disord., 2, 117-123 (1987).
14. Shannak K., Rajput A., Rozdilsky B., Kish S., Gilbert J., Hornykiewicz O., Brain Res., 639, 33-41 (1994).
15. Rinne J. O., Anichtchik O. V., Eriksson K. S., Kaslin J., Tuomisto L., Kalimo H., Röyttä M., Panula P., J. Neurochem., 81, 954-960 (2002).
16. Fulle S., Mariggiò M. A., Belia S., Petrelli C., Ballarini P., Guarnieri S., Fanò G., Neuroscience, 89, 991-997 (1999).
17. Hu J., Castets F., Guevara J. L., Van Eldik L. J., J. Biol. Chem., 271, 2543-2547 (1996).
18. Lam A. G., Koppal T., Akama K. T., Guo L., Craft J. M., Samy B., Schavocky J. P., Watterson D. M., Van Eldik L. J., Neurobiol. Aging, 22, 765-772 (2001).